| bakker, S |
| Recruiting | N/A | 478 | Europe | XELOX regimen according to standard procedures, FOLFOX regimen according to standard procedures, Surgery, radiofrequency ablation (RFA), transarterial chemo-embolization using irinotecan drug-eluted beads ((DEBIRI-)TACE), stereotactic body radiation therapy (SBRT), Bevacizumab, tumor biopsy | Radboud University Medical Center, Erasmus Medical Center | Multi-organ Metastatic Colorectal Cancer | 07/23 | 07/25 | | |
| Cuypers, Philippe |
| Recruiting | N/A | 195 | Europe | Arteriovenous fistula creation, Arteriovenous graft placement, Central venous catheter placement | Maastricht University Medical Center, ZonMw: The Netherlands Organisation for Health Research and Development | Vascular Access Complication, Hemodialysis Access Failure, Dialysis Access Malfunction, Arteriovenous Fistula, Arteriovenous Graft, Central Venous Catheter Related Bloodstream Infection | 12/25 | 12/25 | | |
| Recruiting | N/A | 550 | Europe, Japan, US, RoW | Medtronic Endurant II or Endurant IIs Stent Graft System, Gore Excluder or Gore/ Excluder Conformable AAA Endoprosthesis | Medtronic Cardiovascular | Abdominal Aortic Aneurysm, Abdominal Aortic Aneurysm >= 5.5 Centimeters in Male (Disorder), Abdominal Aortic Aneurysm >= 5.0 Centimeters in Female (Disorder) | 05/27 | 05/31 | | |
| Recruiting | N/A | 204 | Europe | ESAR treatment: Endograft + Heli-FX Endoanchor, FEVAR treatment : Fenestrated endograft | FCRE (Foundation for Cardiovascular Research and Education), Medtronic | Aortic Aneurysm, Abdominal | 06/26 | 06/28 | | |
| Velden, A van der |
DIRECT-2, NCT05503108: Fasting Mimicking Diet Program to ImpRovE ChemoTherapy in Hormone Receptor Postive (HR+), HER2- Breast Cancer |
|
|
| Suspended | 3 | 10 | Europe | Fasting Mimicking diet program, Xentigen™ | Leiden University Medical Center, The Netherlands Cancer Institute, Borstkanker Onderzoek Groep, Comprehensive Cancer Centre The Netherlands, Koningin Wilhelmina Fonds, World Cancer Research Fund International, L-Nutra Inc | Fasting Mimicking Diet, HER2-negative Breast Cancer, Hormone Receptor-positive Breast Cancer, Pathological Complete Response, Objective Response Rate, Neoadjuvant Chemotherapy | 01/24 | 01/24 | | |
| Recruiting | 2 | 320 | Europe | Liposomal Irinotecan, Carboplatin, Capecitabine, Xeloda, Oxaliplatin, 5-fluorouracil, Leucovorin | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA), Servier | Esophageal Cancer | 07/25 | 07/26 | | |
| Recruiting | 2 | 130 | Europe | Alpelisib 150 MG Oral Tablet [Piqray], Piqray, Fulvestrant, Faslodex | Borstkanker Onderzoek Groep, Novartis Pharma B.V., BOOG Study Center | Neoplasm, Breast, Congenital, Familial and Genetic Disorders | 12/24 | 03/28 | | |
COSMO, NCT05301881: COntinue the SaMe Systemic Therapy After Local Ablative Therapy for Oligo Progression in Metastatic Breast Cancer - the Study |
|
|
| Recruiting | 2 | 118 | Europe | Surgery, Radiotherapy, Radiofrequent ablation | The Netherlands Cancer Institute, Maarten van de Weijden Foundation | Breast Cancer Invasive, Metastatic Cancer, Oligoprogressive | 04/35 | 04/40 | | |
| Recruiting | N/A | 50000 | Europe | | Dutch Colorectal Cancer Group | Colorectal Cancer | 01/50 | 01/51 | | |
| Velde, AMT van der |
| Recruiting | 3 | 564 | Europe | FOLFOX/ FOLFIRI with bevacizumab, - bevacizumab, - irinotecan, - leucovorin, - 5-fluorouracil, - oxaliplatin, FOLFOXIRI with bevacizumab, FOLFOX/ FOLFIRI with panitumumab, - panitumumab | Dutch Colorectal Cancer Group | Colorectal Cancer, Liver Metastases | 08/22 | 07/25 | | |
| Hendriks, E |
| Recruiting | 2 | 268 | Europe | Nivolumab, nivolumab (opdivo), Ipilimumab, Ipilimumab (Yervoy), Celecoxib 200mg, Celebrex, BMS-986253, Anti-IL8, BMS-986016, Relatlimab | The Netherlands Cancer Institute, Bristol-Myers Squibb | Colon Carcinoma | 12/24 | 12/24 | | |
| Tent, M |
| Recruiting | N/A | 50000 | Europe | | Dutch Colorectal Cancer Group | Colorectal Cancer | 01/50 | 01/51 | | |
